|
1
|
Gupta S, Barrett T, Whitmarsh AJ, Cavanagh
J, Sluss HK, Derijard B and Davis RJ: Selective interaction of JNK
protein kinase isoforms with transcription factors. EMBO J.
15:2760–2770. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seki E, Brenner DA and Karin M: A liver
full of JNK: Signaling in regulation of cell function and disease
pathogenesis, and clinical approaches. Gastroenterology.
143:307–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brenner C, Galluzzi L, Kepp O and Kroemer
G: Decoding cell death signals in liver inflammation. J Hepatol.
59:583–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kallunki T, Deng T, Hibi M and Karin M:
c-jun Can recruit JNK to phosphorylate dimerization partners via
specific docking interactions. Cell. 87:929–939. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Williams AS, Issa R, Leung SY, Nath P,
Ferguson GD, Bennett BL, Adcock IM and Chung KF: Attenuation of
ozone-induced airway inflammation and hyper-responsiveness by c-Jun
NH2 terminal kinase inhibitor SP600125. J Pharmacol Exp Ther.
322:351–359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nath P, Eynott P, Leung SY, Adcock IM,
Bennett BL and Chung KF: Potential role of c-Jun NH2-terminal
kinase in allergic airway inflammation and remodelling: Effects of
SP600125. Eur J Pharmacol. 506:273–283. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Assi K, Pillai R, Gomez-Munoz A, Owen D
and Salh B: The specific JNK inhibitor SP600125 targets tumour
necrosis factor-alpha production and epithelial cell apoptosis in
acute murine colitis. Immunology. 118:112–121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Mei X, Yuan J, Lai X and Xu D:
Taurine zinc solid dispersions enhance bile-incubated L02 cell
viability and improve liver function by inhibiting ERK2 and JNK
phosphory-lation during cholestasis. Toxicology. 366-367:10–19.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo C, Wang SL, Xu ST, Wang JG and Song
GH: SP600125 reduces lipopolysaccharide-induced apoptosis and
restores the early-stage differentiation of osteoblasts inhibited
by LPS through the MAPK pathway in MC3T3-E1 cells. Int J Mol Med.
35:1427–1434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan H, Gao Y and Zhang Y: Inhibition of
JNK suppresses autophagy and attenuates insulin resistance in a rat
model of nonalcoholic fatty liver disease. Mol Med Rep. 15:180–186.
2017. View Article : Google Scholar :
|
|
12
|
Liu M, Huang G, Wang TT, Sun X and Yu LL:
3-MCPD 1-Palmitate induced tubular cell apoptosis in vivo via
JNK/p53 pathways. Toxicol Sci. 151:181–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Wang Y, Miao X, Zhou S, Tan Y,
Liang G, Zheng Y, Liu Q, Sun J and Cai L: Inhibition of JNK by
compound C66 prevents pathological changes of the aorta in
STZ-induced diabetes. J Cell Mol Med. 18:1203–1212. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Zhou S, Sun W, McClung K, Pan Y,
Liang G, Tan Y, Zhao Y, Liu Q, Sun J and Cai L: Inhibition of JNK
by novel curcumin analog C66 prevents diabetic cardiomyopathy with
a preservation of cardiac metallothionein expression. Am J Physiol
Endocrinol Metab. 306:E1239–E1247. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hirschfield GM, Heathcote EJ and Gershwin
ME: Pathogenesis of cholestatic liver disease and therapeutic
approaches. Gastroenterology. 139:1481–1496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hofmann AF: Cholestatic liver disease:
Pathophysiology and therapeutic options. Liver. 22(Suppl 2):
S14–S19. 2002. View Article : Google Scholar
|
|
17
|
Huang YH, Chuang JH, Yang YL, Huang CC, Wu
CL and Chen CL: Cholestasis downregulate hepcidin expression
through inhibiting IL-6-induced phosphorylation of signal
transducer and activator of transcription 3 signaling. Lab Invest.
89:1128–1139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan Z, Liu A, Luo M, Yin X, Song D, Dai M,
Li P, Chu Z, Zou Z, Ma M, et al: Geniposide inhibits
alpha-naphthylisothio-cyanate-induced intrahepatic cholestasis: The
downregulation of STAT3 and NF[Formula: See text]B signaling plays
an important role. Am J Chin Med. 44:721–736. 2016. View Article : Google Scholar
|
|
19
|
Miyake JH, Wang SL and Davis RA: Bile acid
induction of cytokine expression by macrophages correlates with
repression of hepatic cholesterol 7alpha-hydroxylase. J Biol Chem.
275:21805–21808. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Higuchi H, Grambihler A, Canbay A, Bronk
SF and Gores GJ: Bile acids up-regulate death receptor
5/TRAIL-receptor 2 expression via a c-Jun N-terminal
kinase-dependent pathway involving Sp1. J Biol Chem. 279:51–60.
2004. View Article : Google Scholar
|
|
21
|
Li D, Zimmerman TL, Thevananther S, Lee
HY, Kurie JM and Karpen SJ: Interleukin-1 beta-mediated suppression
of RXR: RAR transactivation of the Ntcp promoter is JNK-dependent.
J Biol Chem. 277:31416–31422. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li T, Jahan A and Chiang JY: Bile acids
and cytokines inhibit the human cholesterol 7 alpha-hydroxylase
gene via the JNK/c-jun pathway in human liver cells. Hepatology.
43:1202–1210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gupta S, Stravitz RT, Dent P and Hylemon
PB: Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene
expression by bile acids in primary rat hepatocytes is mediated by
the c-Jun N-terminal kinase pathway. J Biol Chem. 276:15816–15822.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo R, Wu H, Yu X, Xu M, Zhang X, Tang L
and Wang Z: Simultaneous determination of seven anthraquinone
aglycones of crude and processed semen cassiae extracts in rat
plasma by UPLC-MS/MS and its application to a comparative
pharmacokinetic study. Molecules. 22:18032017. View Article : Google Scholar
|
|
25
|
Chiang JY: Bile acid metabolism and
signaling. Compr Physiol. 3:1191–1212. 2013.PubMed/NCBI
|
|
26
|
Dai M, Yang J, Xie M, Lin J, Luo M, Hua H,
Xu G, Lin H, Song D, Cheng Y, et al: Inhibition of JNK signalling
mediates PPARα-dependent protection against intrahepatic
cholestasis by fenofibrate. Br J Pharmacol. 174:3000–3017. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gonzalez FJ, Jiang C, Xie C and Patterson
AD: Intestinal farnesoid X receptor signaling modulates metabolic
disease. Dig Dis. 35:178–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Holt JA, Luo G, Billin AN, Bisi J, McNeill
YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, et
al: Definition of a novel growth factor-dependent signal cascade
for the suppression of bile acid biosynthesis. Genes Dev.
17:1581–1591. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Inagaki T, Choi M, Moschetta A, Peng L,
Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA,
et al: Fibroblast growth factor 15 functions as an enterohepatic
signal to regulate bile acid homeostasis. Cell Metab. 2:217–225.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dawson PA: Role of the intestinal bile
acid transporters in bile acid and drug disposition. Handb Exp
Pharmacol. 169–203. 2011. View Article : Google Scholar
|
|
31
|
Wu Q, Wu W, Jacevic V, Franca TCC, Wang X
and Kuca K: Selective inhibitors for JNK signalling: A potential
targeted therapy in cancer. J Enzyme Inhib Med Chem. 35:574–583.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanajiri K, Mitsui H, Maruyama T,
Hashimoto N, Sata M and Omata M: Echographic detection of
diethylnitrosamine-induced liver tumors in rats and the effect of
the intratumoral injection of an inhibitor of c-Jun N-terminal
kinase. J Gastroenterol Hepatol. 24:866–871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bennett BL, Sasaki DT, Murray BW, O'Leary
EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et
al: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal
kinase. Proc Natl Acad Sci USA. 98:13681–13686. 2001. View Article : Google Scholar : PubMed/NCBI
|
